The DOI matches its Crossref record.
Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans.
Abstract
In contrast to several inbred strains of mice that develop Th1-associated anticandidal protection, DBA/2 mice are highly susceptible to systemic infection with Candida albicans cells of the attenuated variant PCA-2, and fatal outcome is observed in concurrence with sustained CD4+ cell production in vitro of IL-4 and IL-10. These Th2 cytokines were previously shown to inhibit nitric oxide (NO) production and yeast killing by activated macrophage cultures. We now show that macrophages from DBA/2 mice, either intact or infected with PCA-2, have lower capacity than resistant strains to synthesize NO in response to IFN-gamma. However, when treated with anti-IL-10 Abs at the time of infection, DBA/2 mice survived challenge and displayed increased production of NO in vitro after IFN-gamma activation. Cure was associated with the onset of footpad responses and durable protection, and higher frequencies of IFN-gamma-secreting cells were found in splenic CD4+ lymphocytes that expressed lower levels of IL-4 and IL-10 mRNA. Therefore, in DBA/2 mice, IL-10 contributes significantly to the selection of a Th2 response and lethality after PCA-2 challenge. An IL-10-induced defect in the activation and/or expansion of IFN-gamma-producing Th1 cells, IL-10 suppression of yeast killing, and the relative inability of DBA/2 macrophages to produce adequate levels of candidacidal NO may all contribute to the abnormal susceptibility of these mice to candidiasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Netea, M. G., Sutmuller, R., Hermann, C., Van der Graaf, C. A. A., Van der Meer, J. W. M., van Krieken, J. H., Hartung, T., Adema, G., & Kullberg, B. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3712 · Cited by 609
Antifungal agents: chemotherapeutic targets and immunologic strategies
Georgopapadakou, N. H., & Walsh, T. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.279 · Cited by 498
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice
Screpanti, I., Romani, L., Musiani, P., Modesti, A., Fattori, E., Lazzaro, D., Sellitto, C., Scarpa, S., Bellavia, D., & Lattanzio, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07185.x · Cited by 407
Self-citationGroll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377
Romani, L., Mencacci, A., Cenci, E., Spaccapelo, R., Toniatti, C., Puccetti, P., Bistoni, F., & Poli, V (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1345 · Cited by 313
Self-citationStudies with IL-10-/- mice: an overview
Rennick, D. M., Fort, M. M., & Davidson, N. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.4.389 · Cited by 302
IL-10 mediates susceptibility toLeishmania donovani infection
Murphy, M. L., Wille, U., Villegas, E. N., Hunter, C. A., & Farrell, J. P. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2848::aid-immu2848>3.0.co;2-t · Cited by 275
Cytokine Dysregulation Associated with Exam Stress in Healthy Medical Students
Marshall, G. D., Agarwal, S. K., Lloyd, C., Cohen, L., Henninger, E. M., & Morris, G. J. (1998) · Brain, Behavior, and Immunity · doi:10.1006/brbi.1998.0537 · Cited by 258
Cytokine‐ and T Helper–Dependent Lung Mucosal Immunity in Mice with Invasive Pulmonary Aspergillosis
Cenci, E., Mencacci, A., Fè d'Ostiani, C., Del Sero, G., Mosci, P., Montagnoli, C., Bacci, A., & Romani, L. (1998) · The Journal of Infectious Diseases · doi:10.1086/314493 · Cited by 254
Self-citationIron Overload Alters Innate and T Helper Cell Responses to Candida albicans in Mice
Mencacci, A., Cenci, E., Boelaert, J. R., Bucci, P., Mosci, P., d'Ostiani, C. F., Bistoni, F., & Romani, L. (1997) · The Journal of Infectious Diseases · doi:10.1086/516481 · Cited by 169
Self-citationImmune responses of cattle to African trypanosomes: protective or pathogenic?
Taylor, K. (1998) · International Journal for Parasitology · doi:10.1016/s0020-7519(97)00154-9 · Cited by 121
Innate and adaptive immunity in Candida albicans infections and saprophytism
Romani, L. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.2.175 · Cited by 106
Self-citationIbrahim, A. S., Spellberg, B. J., Avenissian, V., Fu, Y., Filler, S. G., & Edwards, J. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.999-1005.2005 · Cited by 83
IFN-γ Is Required for IL-12 Responsiveness in Mice with Candida albicans Infection
Cenci, E., Mencacci, A., Del Sero, G., Fé d’Ostiani, C., Mosci, P., Bacci, A., Montagnoli, C., Kopf, M., & Romani, L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3543 · Cited by 67
Self-citationMacCallum, D. M. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00576.x · Cited by 56
“IL-10 is known to have strong inhibitory effects on defense against C. albicans (Romani et al., 1994), with IL-10 knockout mice more resistant to C. albicans infection (Vazquez-Torres et al., 1999).”
BackgroundDesoubeaux, G., & Cray, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00841 · Cited by 55
Zhao, W., Wang, X., Zhao, C., & Yan, Z. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104988 · Cited by 9
Metadata
- Authors
- Romani, L., Puccetti, P., Mencacci, A., Cenci, E., Spaccapelo, R., Tonnetti, L., Grohmann, U., & Bistoni, F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-04-01
- Volume
- 152
- Issue
- 7
- Pages
- 3514-3521
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1654658858
- Cited by
- 181
- References
- 0
- FWCI
- 14.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.